NeuroPace NPCE 深 沪
已收盘 08-21 16:00:00 美东时间
14.03
+0.010
+0.07%
华盛通- 最 高14.22
- 今 开14.14
- 成交量 11.60万股
- 最 低 13.87
- 昨 收 14.02
- 总市值 4.82亿
- 52周最高 19.60
- 市盈率 静 --
- 换手率 0.34%
- 52周最低 8.8833
- 委 比 68.62%
- 总股本 3432.43万
- 历史最高 27.38
- 量 比 0.73
- 振 幅 2.50%
- 历史最低 1.22
- 每 手 1
- 风险率 2.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NeuroPace Raises FY2026 Sales Guidance from $99.000M-$101.000M to $99.500M-$101.500M vs $99.913M Est
NeuroPace (NASDAQ:NPCE) raises FY2026 sales outlook from $99.000 million-$101.000 million to $99.500 million-$101.500 million vs $99.913 million estimate.
08-12 04:08
美股大行评级 | 谷歌绩后分歧大！4家大行上调、10家下调目标价；特斯拉遭8家大行下调目标价；ServiceNow、德州仪器、西屋制动、AT&T、CSX等获多家大行上调目标价
今日重点评级关注：伯恩斯坦：维持ServiceNow"跑赢大市"评级，目标价从236美元升至248美元；HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从46美元升至52美元
07-24 11:37
Mizuho Initiates Coverage On NeuroPace with Outperform Rating, Announces Price Target of $22
Mizuho analyst Anthony Petrone initiates coverage on NeuroPace (NASDAQ:NPCE) with a Outperform rating and announces Price Target of $22.
07-23 18:13
NeuroPace To Highlight Expanding Role Of Responsive Neuromodulation In Epilepsy Care In 2026 ASSFN Meeting
--ASSFN program to feature thalamic neuromodulation, NAUTILUS data in idiopathic generalized epilepsy, and emerging applications for broader epilepsy populations----NeuroPace to engage neurosurgeon community through
05-29 20:13
美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
05-18 11:48
HC Wainwright & Co. Maintains Buy on NeuroPace, Raises Price Target to $20
HC Wainwright & Co. analyst Yi Chen maintains NeuroPace (NASDAQ:NPCE) with a Buy and raises the price target from $19 to $20.
05-16 01:35
Neuropace shares are trading lower. The company reported Q1 financial results.
Neuropace shares are trading lower. The company reported Q1 financial results.
05-13 21:19
NeuroPace Reports Q1 2026 Results: Full Earnings Call Transcript
NeuroPace (NASDAQ:NPCE) released first-quarter financial results and hosted an ...
05-13 05:38
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
Neuropace shares are trading higher after the company reported better-than-expected Q4 financial results.
Neuropace shares are trading higher after the company reported better-than-expe...
03-04 05:14
